QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, has expanded its U.S.-based Phase I clinical trial capabilities to support the growing needs of its pharmaceutical, biotechnology and CRO partners.    To meet growing client demand in all areas the CRO has increased early-phase clinical capacity by more than 20 percent at its clinical site in Miami, FL. In addition, it doubled its specialty lab space at its Miami site ...